You are here

Home

Clinical Trials: Eye Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, August 1, 2016 - 12:00
Study of NT-501 Encapsulated Cell Therapy for Glaucoma
Condition:   Glaucoma
Interventions:   Drug: NT-501 ECT implant;   Other: Sham
Sponsor:   Stanford University
Recruiting - verified August 2016
Posted: Thursday, June 9, 2016 - 12:00
Neurologic Stem Cell Treatment Study
Conditions:   Neurologic Disorders;   Nervous System Diseases;   Neurodegenerative Diseases;   Neurological Disorders;   Stroke;   Traumatic Brain Injury;   Cadasil;   Chronic Traumatic Encephalopathy;   Cerebral Infarction;   Cerebral Ischemia;   Cerebral Stroke;   Cerebral Hemorrhage;   Parkinson;   Multi-System Degeneration;   MSA - Multiple System Atrophy;   Progressive Supranuclear Palsy;   ALS;   Amyotrophic Lateral Sclerosis;   Neuropathy;   Diabetic Neuropathies
Interventions:   Procedure: Intravenous BMSC;   Procedure: Intranasal BMSC
Sponsors:   MD Stem Cells;   The Healing Institute
Recruiting
Posted: Saturday, March 26, 2016 - 12:00
Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases
Condition:   Dry Age-related Macular Degeneration
Intervention:   Biological: retinal pigment epithelium transplantation
Sponsors:   Chinese Academy of Sciences;   Beijing Tongren Hospital
Recruiting - verified December 2016
Posted: Monday, March 7, 2016 - 12:00
Stem Cell Therapy for Outer Retinal Degenerations
Conditions:   Age Related Macular Degeneration;   Stargardt's Disease;   Exudative Age-related Macular Degeneration
Interventions:   Procedure: injection of hESC-RPE in suspension;   Procedure: injection hESC-RPE seeded in a substrate
Sponsor:   Federal University of São Paulo
Recruiting - verified September 2016
Posted: Friday, February 26, 2016 - 12:00
Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa
Condition:   Retinitis Pigmentosa
Intervention:   Biological: Stem Cell Transplantation
Sponsor:   Stem Cells Arabia
Recruiting - verified February 2016
Posted: Thursday, January 7, 2016 - 12:00
Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases
Conditions:   Macular Degeneration;   Stargardt's Macular Dystrophy
Intervention:   Procedure: Subretinal transplantation
Sponsor:   Southwest Hospital, China
Recruiting - verified April 2016
Posted: Wednesday, December 23, 2015 - 12:00
Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells
Condition:   Optic Neuropathy
Intervention:   Biological: Stem Cells
Sponsor:   Stem Cells Arabia
Recruiting
Posted: Friday, October 23, 2015 - 12:00
Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD
Conditions:   Dry Macular Degeneration;   Geographic Atrophy
Intervention:   Biological: CPCB-RPE1
Sponsor:   Regenerative Patch Technologies, LLC
Recruiting - verified January 2016
Posted: Wednesday, June 10, 2015 - 12:00
Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose
Condition:   Uveitis
Intervention:   Other: intravitreous administration of regulator T-cells
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2015
Posted: Monday, May 18, 2015 - 12:00
Safety and Tolerability of hRPC in Retinitis Pigmentosa
Condition:   Retinitis Pigmentosa
Intervention:   Drug: hRPC
Sponsor:   ReNeuron Limited
Recruiting - verified December 2015

Pages